Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aroa Biosurgery Ltd (AU:ARX)
ASX:ARX
RESEARCH TOOLSreports
Holding AU:ARX?
Track your performance easily
ARX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.44 - AU$0.87
Previous CloseAU$0.51
Volume44.54K
Average Volume (3M)894.05K
Market Cap
AU$181.07M
Enterprise ValueAU$133.18M
Total Cash (Recent Filing)AU$53.35M
Total Debt (Recent Filing)AU$5.46M
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Nov 26, 2024EPS Estimate
>-AU$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares OutstandingN/A
10 Day Avg. Volume375,309
30 Day Avg. Volume894,051
Standard Deviation0.11
R-Squared0.19
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)7.84
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.94Price Target Upside88.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Aroa Biosurgery Ltd News
PremiumCompany Announcements
Aroa Biosurgery’s Shift in Shareholder Voting PowerPremiumCompany Announcements
FirstCape Group Ups Stake in Aroa Biosurgery
PremiumCompany Announcements
Aroa Biosurgery Director’s Major Share Acquisition
PremiumCompany Announcements
Aroa Biosurgery Director’s Stake Increases
PremiumCompany Announcements
Aroa Biosurgery Applies for ASX Quotation
PremiumCompany Announcements
Aroa Biosurgery Seeks Quotation for New SecuritiesPremiumCompany Announcements
Aroa Biosurgery Issues New Performance Rights
PremiumCompany Announcements
Aroa Biosurgery’s Educational Quarterly InsightOptions Prices
Currently, No data available
---
Ownership Overview
7.62% Insiders
0.07% Mutual Funds
<0.01% Other Institutional Investors
92.31% Public Companies and
Individual Investors
ARX FAQ
What was Aroa Biosurgery Ltd’s price range in the past 12 months?
Aroa Biosurgery Ltd lowest share price was AU$0.44 and its highest was AU$0.87 in the past 12 months.
What is Aroa Biosurgery Ltd’s market cap?
Currently, no data Available
When is Aroa Biosurgery Ltd’s upcoming earnings report date?
Aroa Biosurgery Ltd’s upcoming earnings report date is Nov 26, 2024 which is in 79 days.
How were Aroa Biosurgery Ltd’s earnings last quarter?
Aroa Biosurgery Ltd released its earnings results on May 20, 2024. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of -AU$0.003 by -AU$0.008.
Is Aroa Biosurgery Ltd overvalued?
According to Wall Street analysts Aroa Biosurgery Ltd’s price is currently Undervalued.
Does Aroa Biosurgery Ltd pay dividends?
Aroa Biosurgery Ltd does not currently pay dividends.
What is Aroa Biosurgery Ltd’s EPS estimate?
Aroa Biosurgery Ltd’s EPS estimate is >-AU$0.01.
How many shares outstanding does Aroa Biosurgery Ltd have?
Aroa Biosurgery Ltd has 344,900,270 shares outstanding.
What happened to Aroa Biosurgery Ltd’s price movement after its last earnings report?
Aroa Biosurgery Ltd reported an EPS of -AU$0.011 in its last earnings report, missing expectations of -AU$0.003. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aroa Biosurgery Ltd?
Currently, no hedge funds are holding shares in AU:ARX
---
Aroa Biosurgery Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$0.94 (88.00% Upside)
AU$0.94 (88.00% Upside)
Blogger Sentiment
Bullish
AU:ARX Sentiment 100%
Sector Average 69%
Sector Average 69%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.55%
12-Months-Change
Fundamentals
Return on Equity
-10.81%
Trailing 12-Months
Asset Growth
-6.46%
Trailing 12-Months
Company Description
Aroa Biosurgery Ltd
Aroa Biosurgery Ltd is a soft tissue regeneration company. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company's principal market is the United States where it has five key products for sale targeting chronicwounds, hernia, plastics, and reconstructive surgery and trauma/limb salvage/tumor surgery.
---
ARX Stock 12 Month Forecast
Average Price Target
AU$0.94
▲(88.00% Upside)
Technical Analysis
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Regeneus Ltd.
―
Adherium Ltd.
―
Best Analysts Covering ARX
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-14.06%
reiterated a buy rating 26 days ago
Copying Shane Storey's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -14.06% per trade.
---